Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer
- PMID: 25206306
- PMCID: PMC4157396
- DOI: 10.2147/PGPM.S38117
Dysregulation of the homeobox transcription factor gene HOXB13: role in prostate cancer
Abstract
Prostate cancer (PC) is the most common noncutaneous cancer in men, and epidemiological studies suggest that about 40% of PC risk is heritable. Linkage analyses in hereditary PC families have identified multiple putative loci. However, until recently, identification of specific risk alleles has proven elusive. Cooney et al used linkage mapping and segregation analysis to identify a putative risk locus on chromosome 17q21-22. In search of causative variant(s) in genes from the candidate region, a novel, potentially deleterious G84E substitution in homeobox transcription factor gene HOXB13 was observed in multiple hereditary PC families. In follow-up testing, the G84E allele was enriched in cases, especially those with an early diagnosis or positive family history of disease. This finding was replicated by others, confirming HOXB13 as a PC risk gene. The HOXB13 protein plays diverse biological roles in embryonic development and terminally differentiated tissue. In tumor cell lines, HOXB13 participates in a number of biological functions, including coactivation and localization of the androgen receptor and FOXA1. However, no consensus role has emerged and many questions remain. All HOXB13 variants with a proposed role in PC risk are predicted to damage the protein and lie in domains that are highly conserved across species. The G84E variant has the strongest epidemiological support and lies in a highly conserved MEIS protein-binding domain, which binds cofactors required for activation. On the basis of epidemiological and biological data, the G84E variant likely modulates the interaction between the HOXB13 protein and the androgen receptor, as well as affecting FOXA1-mediated transcriptional programming. However, further studies of the mutated protein are required to clarify the mechanisms by which this translates into PC risk.
Keywords: HOXB13; prostate cancer risk.
Figures

Similar articles
-
HOXB13 interaction with MEIS1 modifies proliferation and gene expression in prostate cancer.Prostate. 2019 Mar;79(4):414-424. doi: 10.1002/pros.23747. Epub 2018 Dec 17. Prostate. 2019. PMID: 30560549
-
Evaluation of homeobox protein B13 (HOXB13) gene G84E mutation in patients with prostate cancer.World J Urol. 2024 Aug 8;42(1):476. doi: 10.1007/s00345-024-05186-9. World J Urol. 2024. PMID: 39115757
-
A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.Eur Urol. 2014 Jan;65(1):169-76. doi: 10.1016/j.eururo.2012.07.027. Epub 2012 Jul 20. Eur Urol. 2014. PMID: 22841674
-
Homeobox B13 G84E Mutation and Prostate Cancer Risk.Eur Urol. 2019 May;75(5):834-845. doi: 10.1016/j.eururo.2018.11.015. Epub 2018 Dec 8. Eur Urol. 2019. PMID: 30527799 Free PMC article.
-
Screening for familial and hereditary prostate cancer.Int J Cancer. 2016 Jun 1;138(11):2579-91. doi: 10.1002/ijc.29949. Epub 2016 Feb 5. Int J Cancer. 2016. PMID: 26638190 Review.
Cited by
-
Epidemiology and genomics of prostate cancer in Asian men.Nat Rev Urol. 2021 May;18(5):282-301. doi: 10.1038/s41585-021-00442-8. Epub 2021 Mar 10. Nat Rev Urol. 2021. PMID: 33692499 Review.
-
HOXB13 expression and promoter methylation as a candidate biomarker in gastric cancer.Oncol Lett. 2018 Jun;15(6):8833-8840. doi: 10.3892/ol.2018.8371. Epub 2018 Mar 29. Oncol Lett. 2018. PMID: 29928325 Free PMC article.
-
HOXB13 and TFF3 can contribute to the prognostic stratification of prostate adenocarcinoma.Rom J Morphol Embryol. 2021 Jan-Mar;62(1):41-52. doi: 10.47162/RJME.62.1.04. Rom J Morphol Embryol. 2021. PMID: 34609407 Free PMC article.
-
Characterization of HOXB13 expression patterns in localized and metastatic castration-resistant prostate cancer.J Pathol. 2024 Jan;262(1):105-120. doi: 10.1002/path.6216. Epub 2023 Oct 18. J Pathol. 2024. PMID: 37850574 Free PMC article.
-
Overexpression of homeobox B-13 correlates with angiogenesis, aberrant expression of EMT markers, aggressive characteristics and poor prognosis in pancreatic carcinoma.Int J Clin Exp Pathol. 2015 Jun 1;8(6):6919-27. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261579 Free PMC article.
References
-
- Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30. - PubMed
-
- Grönberg H, Damber L, Damber JE. Studies of genetic factors in prostate cancer in a twin population. J Urol. 1994;152(5 Pt 1):1484–1487. discussion 1487–1489. - PubMed
-
- Lichtenstein P, Holm NV, Verkasalo PK, et al. Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med. 2000;343(2):78–85. - PubMed
-
- Verkasalo PK, Kaprio J, Koskenvuo M, Pukkala E. Genetic predisposition, environment and cancer incidence: a nationwide twin study in Finland, 1976–1995. Int J Cancer. 1999;83(6):743–749. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials